Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Schissel Mark J

2. Date of Event Requiring Statement (MM/DD/YYYY) 8/1/2017

3. Issuer Name and Ticker or Trading Symbol

HERBALIFE LTD. [HLF]

(Last) (First) (Middle)

800 W. OLYMPIC BLVD., SUITE 406

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
EVP, WW Operations /

(Street)

LOS ANGELES, CA 90015

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1200	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Appreciation Right	12/19/2013 ⁽¹⁾	12/19/2023	Common Stock	6809	$79.58	D
Stock Appreciation Right	4/30/2014 ⁽²⁾	4/30/2024	Common Stock	8631	$59.98	D
Stock Appreciation Right	3/2/2015 ⁽³⁾	3/2/2025	Common Stock	8442	$30.44	D
Stock Appreciation Right	5/9/2016 ⁽⁴⁾	5/9/2026	Common Stock	6298	$62.51	D
Stock Appreciation Right	2/27/2017 ⁽⁵⁾	2/27/2027	Common Stock	6091	$57.19	D

Explanation of Responses:
(1)	On December 19, 2013, the reporting person was granted 6,809 Stock Appreciation Rights ("SARs"). These SARs were fully as of December 19, 2016.
(2)	On April 30, 2014, the reporting person was granted 8,631 SARs. These SARs were fully vested as of April 30, 2017.
(3)	On March 2, 2015, the reporting person was granted 14,070 SARs. Forty percent (40%) of these SARs were vested as of March 2, 2017, and the remaining sixty percent (60%) will vest on March 2, 2018.
(4)	On May 9, 2016, the reporting person was granted 6,298 SARs. Twenty percent (20%) of these SARs were vested as of May 9, 2017, twenty percent (20%) will vest on May 9, 2018, and the remaining sixty percent (60%) will vest on May 9, 2019.
(5)	On February 27, 2017, the reporting person was granted 6,091 SARs. Twenty percent (20%) of these SARs will vest each on February 27, 2018 and February 27, 2019, and the remaining sixty percent (60%) will vest on February 27, 2020.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Schissel Mark J 800 W. OLYMPIC BLVD., SUITE 406 LOS ANGELES, CA 90015			EVP, WW Operations

Signatures
/s/ Eileen Uy, Attorney-in-Fact for Mark J. Schissel		8/4/2017
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.